Skip to main content
Nelli Bejanyan, MD, Oncology, Tampa, FL, H. Lee Moffitt Cancer Center and Research Institute

NelliBejanyanMD

Oncology Tampa, FL

Hematologic Oncology

Program Leader of BMT, Section Head of Leukemia/Myeloid BMT-CI

Overview of Dr. Bejanyan

Dr. Nelli Bejanyan is an oncologist in Tampa, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute and M Health Fairview Southdale Hospital. She received her medical degree from Yerevan State Medical University and has been in practice 18 years. Dr. Bejanyan accepts several types of health insurance, listed below. She is one of 173 doctors at H. Lee Moffitt Cancer Center and Research Institute and one of 50 doctors at M Health Fairview Southdale Hospital who specialize in Oncology. She has more than 90 publications and over 500 citings.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Bone Marrow Failure Diseases , 2008 - 2009
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2007 - 2008
  • St Vincent Hospital
    St Vincent HospitalResidency, Internal Medicine, 2005 - 2007
  • Yerevan State Medical University
    Yerevan State Medical UniversityClass of 1999

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2017 - 2026
  • MN State Medical License
    MN State Medical License 2012 - 2018
  • OH State Medical License
    OH State Medical License 2006 - 2013
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Diffuse Alveolar Hemorrhage Is Most Often Fatal and Is Affected by Graft Source, Conditioning Regiment Toxicity, and Engraftment Kinetics  
    Erhan H Dincer, Erica D Warlick, Margaret L MacMillan, Patrick Arndt, Daniel J Weisdorf, Nelli Bejanyan, Claudio G Brunstein, Celalettin Ustun, Aleksandr Lazaryan, Ver..., Haematologica

Abstracts/Posters

  • Romiplostim Improves Platelet Recovery after UCB Transplant
    Nelli Bejanyan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Impact of TP53 gene Mutation Clearance and Conditioning Intensity on Outcome in MDS or AML Patients Prior to Allogeneic Stem Cell Transplantation
    Nelli Bejanyan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • CD34+ Cell Dose Influences Survival after Allogeneic Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Nelli Bejanyan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Myeloablative Conditioning Is Preferred for Allogeneic Transplantation of Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate but Not High Disea... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Personal Loss Plays ‘Profound Role’ in Shaping Doctor’s Career Path
    Personal Loss Plays ‘Profound Role’ in Shaping Doctor’s Career PathJune 12th, 2024

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    BCBS Blue Card PPO
    BCBS Illinois PPO
    BCBS Minnesota Blue Cross Accord
    CIGNA Open Access
    Humana ChoiceCare Network PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
    WEA Trust Preferred Provider Plan - Trust Pref
  • Please verify your coverage with the provider's office directly when scheduling an appointment